Skip to main content
. 2014 Jan 9;2014:354172. doi: 10.1155/2014/354172

Table 4.

Summary of geometric mean, geometric mean ratio, and 90% confidence internal (90% CI) of pharmacokinetic parameters between WM and WM + CMF1.

Analyte Parameters Geometric mean GM Ratio, %b 90% CI, %c
WM 
(n = 14)
WM + CMF1 
(n = 14)
OA C max (ng/mL) 62.42 48.81 78.19 60.82–100.51
AUC0–12 h (ng·h/mL) 129.86 124.76 96.08 88.48–104.33
12 h Cum. amt. (μg)a 2745.53 2726.98 99.32 85.56–115.30

OC C max (ng/mL) 526.27 480.59 91.32 84.81–98.33
AUC0–12 h (ng·h/mL) 4453.91 4067.40 91.32 83.80–99.52
12 h Cum. amt. (μg)a 71215.61 61224.10 85.97 76.64–96.44

OC/OA AUC0–12 h ratio 34.30 32.60 95.05 85.64–105.50
12 h Cum. amt. ratio 25.94 22.45 86.56 76.49–97.94

a12 h cumulative amount of analyte in urine.

bGeometric mean ratio of (WM + CMF1)/WM.

c90% CI criteria of 80%–125% [10].